Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Operating Expenses: 2019-2025

Historic Operating Expenses for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$68.2 million.

  • CureVac N.V's Operating Expenses fell 34.73% to -$68.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $211.4 million, marking a year-over-year decrease of 7.81%. This contributed to the annual value of $238.0 million for FY2024, which is 6.61% up from last year.
  • As of Q2 2025, CureVac N.V's Operating Expenses stood at -$68.2 million, which was down 20.11% from -$56.8 million recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Operating Expenses ranged from a high of $409.6 million in Q4 2024 and a low of -$193.5 million during Q2 2021.
  • For the 3-year period, CureVac N.V's Operating Expenses averaged around $33.2 million, with its median value being -$51.0 million (2024).
  • Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 298,856.86% in 2022, then spiked by 17,225,200.57% in 2023.
  • Over the past 5 years, CureVac N.V's Operating Expenses (Quarterly) stood at $4,659 in 2021, then tumbled by 52.55% to $2,211 in 2022, then spiked by 17,225,200.57% to $380.8 million in 2023, then climbed by 7.56% to $409.6 million in 2024, then plummeted by 34.73% to -$68.2 million in 2025.
  • Its last three reported values are -$68.2 million in Q2 2025, -$56.8 million for Q1 2025, and $409.6 million during Q4 2024.